Characteristics | n (Total n=70) | |
---|---|---|
 | HCC (n=33) | ICC (n=37) |
Age (median/range) | 66 (38–76) | 59 (41–79) |
Gender (f/m) | 8/25 | 22/15 |
Primary tumour: | Â | Â |
 Primary/recurrent | 8/25 | 19/18 |
 Grading (G1/G2/G3/n.a.) | 1/11/20/12 | 3/17/7/10 |
 Child-Pugh class A/B/C/n.a. | 25/3/1/4 | -- |
 Stage IVb | 10 | 21 |
Pretreatment: | Â | Â |
 Hepatic resection | 18 | 12 |
 Liver transplantation | 5 | 0 |
 Sorafenib/Chemotherapy | 1 | 6 |
 Chemoembolisation | 12 | 1 |
 Local ablation (RFA, brachytherapy) | 2 | 2 |
Elevated AFP/Ca 19-9 | 24 | 32 |